Dr. Geoffrey L. Uy
Claim this profileWashington University School of Medicine
About Geoffrey L. Uy
Education:
- Earned an MD from Washington University School of Medicine.
Experience:
- Over 21 years of clinical experience as an oncologist.
- Specializes in Oncology, with a subspecialty in Hematologic Oncology.
- Affiliated with Barnes-Jewish Hospital and Siteman Cancer Center.
- Recognized for exceptional patient care and high satisfaction ratings.
Area of expertise
Acute Myeloid Leukemia
Geoffrey L. Uy has run 14 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Intestinal Maturation
Geoffrey L. Uy has run 5 trials for Intestinal Maturation. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Siteman Cancer Center At West County Hospital
Clinical Trials Geoffrey L. Uy is currently running
Inotuzumab Ozogamicin + Chemotherapy
for Leukemia
This phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a chemotherapy drug called ozogamicin. Inotuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as CD22 receptors, and delivers ozogamicin to kill them. Chemotherapy drugs, such as \[intervention\], work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia.
Recruiting
2 awards
Phase 3
3 criteria
Screening Tool
for Myeloid Cancer
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical trials throughout the course of their myeloid cancer (acute myeloid leukemia or myelodysplastic syndrome) treatment. This study involves testing patients' bone marrow and blood for certain biomarkers. A biomarker (sometimes called a marker) is any molecule in the body that can be measured. Doctors look at markers to learn what is happening in the body. Knowing about certain markers can give doctors more information about what is driving the cancer and how to treat it. Testing patients' bone marrow and blood will show doctors if patients have markers that specific drugs can target. The marker testing in this study will let doctors know if they can match patients with a treatment study (myeloMATCH clinical trial) that tests treatment for the type of cancer they have or continue standard of care treatment with their doctor on the Tier Advancement Pathway (TAP).
Recruiting
0 awards
Phase 2
1 criteria
More about Geoffrey L. Uy
Clinical Trial Related
3 years of experience running clinical trials · Led 28 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Geoffrey L. Uy has experience with
- Cytarabine
- Cyclophosphamide
- Dexamethasone
- Uproleselan
- Cytokine Induced Memory-like NK Cell Adoptive Therapy
- Isatuximab
Breakdown of trials Geoffrey L. Uy has run
Acute Myeloid Leukemia
Intestinal Maturation
Multiple Myeloma
Myelodysplastic Syndrome
Graft-versus-Host Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Geoffrey L. Uy specialize in?
Geoffrey L. Uy focuses on Acute Myeloid Leukemia and Intestinal Maturation. In particular, much of their work with Acute Myeloid Leukemia has involved FLT3 negative patients, or patients who are FLT3 positive.
Is Geoffrey L. Uy currently recruiting for clinical trials?
Yes, Geoffrey L. Uy is currently recruiting for 5 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Geoffrey L. Uy has studied deeply?
Yes, Geoffrey L. Uy has studied treatments such as Cytarabine, Cyclophosphamide, Dexamethasone.
What is the best way to schedule an appointment with Geoffrey L. Uy?
Apply for one of the trials that Geoffrey L. Uy is conducting.
What is the office address of Geoffrey L. Uy?
The office of Geoffrey L. Uy is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.